byiShook Opinion
Jul 26, 2024 - 04:10
AbbVie stock slipped Thursday despite a second-quarter beat that included strong Skyrizi sales and a boost to 2024 earnings guidance. The post AbbVie Is About To Have A New Golden Goose As Humira Sales Continue Slowing appeared first on Investor's Business Daily.
AbbVie stock slipped Thursday despite a second-quarter beat that included strong Skyrizi sales and a boost to 2024 earnings guidance.
The post AbbVie Is About To Have A New Golden Goose As Humira Sales Continue Slowing appeared first on Investor's Business Daily.